Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Seema Singhal, Jayesh Mehta, Raman Desikan et al. · New England Journal of Medicine · 1999 · 2.6K citations · Full text

Medicine, Hematology, Oncology +14

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations

Medicine, Pharmacology, Pharmacotherapy +14

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Paul G. Richardson, Robert Schlossman, Edie Weller et al. · Blood · 2002 · 804 citations · Full text

Medicine, Immunology, Pharmacology +12

Bone marrow angiogenesis and progression in multiple myeloma

Angelo Vacca, Doménico Ribatti, Luisa Roncali et al. · British Journal of Haematology · 1994 · 641 citations

Medicine, Oncology, Pathology +16

Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma

Angelo Vacca, Doménico Ribatti, Marco Presta et al. · Blood · 1999 · 579 citations

Medicine, Cell Biology, Oncology +16